Skip to content
10-Q

Quarterly Report

NEXUS BIOPHARMA INC

0001477932-16-010139

← back to feed
Filed
May 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · Apr 30, 2016 63.8M sh
Shares Diluted Q1 2016 · Mar 31, 2016 63.8M sh
Shares Diluted Q1 2016 · Mar 31, 2015 63.8M sh
Operating Cash Flow Q1 2016 · Mar 31, 2016 $0
Operating Cash Flow Q1 2016 · Mar 31, 2015 $0
Stockholders Equity Q1 2016 · Mar 31, 2016 −$92.72K
Stockholders Equity Q1 2016 · Dec 31, 2015 −$85.42K
Total Liabilities Q1 2016 · Mar 31, 2016 $92.72K
Total Liabilities Q1 2016 · Dec 31, 2015 $85.42K
Total Assets Q1 2016 · Mar 31, 2016 $0
Total Assets Q1 2016 · Dec 31, 2015 $0
Sga Expense Q1 2016 · Mar 31, 2016 $7.3K
Sga Expense Q1 2016 · Mar 31, 2015 $20.17K
Net Income Q1 2016 · Mar 31, 2016 −$7.3K
Net Income Q1 2016 · Mar 31, 2015 −$20.17K